FDA NDC Directory · JSON-LD · Markdown

rizatriptan benzoate

NDC 68462-467 · HUMAN PRESCRIPTION DRUG · TABLET, ORALLY DISINTEGRATING

Labeler / ManufacturerGlenmark Pharmaceuticals Inc., USA
Marketing categoryAbbreviated NDA (generic) · App ANDA201914
Dosage form / routeTABLET, ORALLY DISINTEGRATING · ORAL
Active ingredientsRIZATRIPTAN BENZOATE (5 mg/1)
Marketing started20130701
Package count2

External sources

Source: openFDA. Public-domain (CC0).